Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mocetinostat and gemcitabine in metastatic leiomyosarcoma
NCT02303262Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mocetinostat in leiomyosarcoma (LMS), sponsored by Sarcoma Alliance for Research through Collaboration. Started Nov 2015; status: completed.
02
Drugs
mocetinostat
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT02303262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303262.